Abeona Therapeutics (ABEO) Short-term Investments (2011 - 2026)

Abeona Therapeutics' Short-term Investments history runs 11 years deep, the most recent figure standing at $106.9 million for Q1 2026.

• On a quarterly basis, Short-term Investments rose 56.7% year-over-year to $106.9 million in Q1 2026; TTM through Mar 2026 was $106.9 million, a 56.7% increase from a year earlier, with the FY2025 full-year figure at $113.0 million, up 51.91% from the prior year.
• Short-term Investments slipped to $106.9 million in Q1 2026 per ABEO's latest filing, from $113.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $124.2 million in Q3 2025 and bottomed at $11.0 million in Q1 2022.
• The 5-year median for Short-term Investments is $49.0 million (2023), against an average of $59.1 million.
• Across the five-year window, Short-term Investments slumped 84.84% in 2022 and soared 294.42% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $37.9 million in 2022, then retreated by 0.47% to $37.8 million in 2023, then jumped by 96.97% to $74.4 million in 2024, then surged by 51.91% to $113.0 million in 2025, then fell by 5.37% to $106.9 million in 2026.
• Per Business Quant, the three latest ABEO Short-term Investments figures stand at $106.9 million (Q1 2026), $113.0 million (Q4 2025), and $124.2 million (Q3 2025).